{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:45:33Z","timestamp":1792003533141,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It has been demonstrated that scar tissue and fibrosis may increase the likelihood of developing malignancies. Specifically, scar tissue has been linked to the occurrence and progression of lung cancer (LC), though the precise mechanisms necessitate further research for explanation. Lung scarring can stem from various causes, with carcinogenesis on scarring lesions in pulmonary tuberculosis (PTB) being the most frequent (accounting for approximately 75% of cases). Notably, having previously cured, PTB is the second most common risk factor for LC after smoking, with approximately 3% of PTB patients experiencing LC as a secondary condition. This essay will delve into the mechanisms, treatment, and prognosis of tuberculosis scar carcinoma (TSC).<\/jats:p>","DOI":"10.1007\/s10555-023-10128-9","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T22:01:41Z","timestamp":1692136901000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["New progress of tuberculosis scar carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Wenwen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-0778","authenticated-orcid":false,"given":"Yujin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"10128_CR1","unstructured":"(2020). World Health Organization 2020."},{"issue":"5","key":"10128_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.rcl.2012.06.006","volume":"50","author":"P de Groot","year":"2012","unstructured":"de Groot, P., & Munden, R. F. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiologic Clinics of North America, 50(5), 863\u2013876.","journal-title":"Radiologic Clinics of North America"},{"key":"10128_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijmyco.2015.07.001","volume":"5","author":"R Ayman","year":"2016","unstructured":"Ayman, R., Glen, H., Ahmad, A., et al. (2016). A case of tuberculosis and adenocarcinoma coexisting in the same lung lobe. International Journal of Mycobacteriology, 5, 80\u201382.","journal-title":"International Journal of Mycobacteriology"},{"issue":"10","key":"10128_CR4","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.21037\/tlcr-21-465","volume":"10","author":"K Xiong","year":"2021","unstructured":"Xiong, K., Sun, W., He, Y., & Fan, L. (2021). Advances in molecular mechanisms of interaction between Mycobacterium tuberculosis and lung cancer: A narrative review. Translational Lung Cancer Research, 10(10), 4012\u20134026.","journal-title":"Translational Lung Cancer Research"},{"key":"10128_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1477-7819-5-22","volume":"5","author":"S Cicenas","year":"2007","unstructured":"Cicenas, S., & Vencevicius, V. (2007). Lung cancer in patients with tuberculosis. World Journal of Surgical Oncology, 5, 22.","journal-title":"World Journal of Surgical Oncology"},{"issue":"1","key":"10128_CR6","first-page":"230","volume":"304","author":"G Friedrich","year":"1939","unstructured":"Friedrich, G. (1939). Peripheral lung cancers on the floor near pleural scars. Virchows Archiv f\u00fcr Pathologische Anatomie und Physiologie und f\u00fcr Klinische Medizin, 304(1), 230\u2013247.","journal-title":"Virchows Archiv f\u00fcr Pathologische Anatomie und Physiologie und f\u00fcr Klinische Medizin"},{"key":"10128_CR7","doi-asserted-by":"publisher","unstructured":"Brett S, Irusen EM, Koegelenberg CFN. (2020). Pulmonary scarring and its relation to primary lung cancer. African Journal of Thoracic and Critical Care Medicine 26(1), https:\/\/doi.org\/10.7196\/AJTCCM.2020.v26i1.050","DOI":"10.7196\/AJTCCM.2020.v26i1.050"},{"issue":"6","key":"10128_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0003-4975(10)65693-7","volume":"17","author":"LJ Freant","year":"1974","unstructured":"Freant, L. J., Joseph, W. L., & Adkins, P. C. (1974). Scar carcinoma of the lung. Fact or fantasy? The Annals of Thoracic Surgery, 17(6), 531\u20137.","journal-title":"The Annals of Thoracic Surgery"},{"issue":"2","key":"10128_CR9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/1097-0142(197902)43:2<636::AID-CNCR2820430234>3.0.CO;2-7","volume":"43","author":"O Auerbach","year":"1979","unstructured":"Auerbach, O., Garfinkel, L., & Parks, V. R. (1979). Scar cancer of the lung: Increase over a 21 year period. Cancer, 43(2), 636\u2013642.","journal-title":"Cancer"},{"issue":"5","key":"10128_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/BF00955185","volume":"325","author":"CJ Luders","year":"1954","unstructured":"Luders, C. J., & Themel, K. G. (1954). Die Narbenkrebse der Lungen als Beitrag zur Pathogenese des peripheren Lungencarcinoms [Cicatricial cancers of the lungs as a contribution to the pathogenesis of the peripheral carcinoma of the lungs]. Virchows Archiv for Pathologische Anatomie und Physiologie und for Klinische Medizin, 325(5), 499\u2013551.","journal-title":"Virchows Archiv for Pathologische Anatomie und Physiologie und for Klinische Medizin"},{"key":"10128_CR11","doi-asserted-by":"publisher","unstructured":"Brett S, Irusen EM, Koegelenberg CFN. (2020). Pulmonary scarring and its relation to primary lung cancer. Afr J Thorac Crit Care Med., 26(1) https:\/\/doi.org\/10.7196\/AJTCCM.2020.v26i1.050.","DOI":"10.7196\/AJTCCM.2020.v26i1.050"},{"issue":"10","key":"10128_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/thx.44.10.788","volume":"44","author":"PC Bodegom","year":"1989","unstructured":"Bodegom, P. C., Wagenaar, S. S., Corrin, B., Baak, J. P., Berkel, J., & Vanderschueren, R. G. (1989). Second primary lung cancer: Importance of long term follow up. Thorax, 44(10), 788\u2013793.","journal-title":"Thorax"},{"issue":"4","key":"10128_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/14737140.8.4.605","volume":"8","author":"EA Engels","year":"2008","unstructured":"Engels, E. A. (2008). Inflammation in the development of lung cancer: Epidemiological evidence. Expert Review of Anticancer Therapy, 8(4), 605\u2013615.","journal-title":"Expert Review of Anticancer Therapy"},{"key":"10128_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/ijc.24042","volume":"124","author":"EASM Engels","year":"2009","unstructured":"Engels, E. A. S. M., Chapman, R. S., Pfeiffer, R. M., et al. (2009). Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. International Journal of Cancer, 124, 1183\u20131187.","journal-title":"International Journal of Cancer"},{"key":"10128_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.1987.233","volume":"56","author":"W Zheng","year":"1987","unstructured":"Zheng, W., Blot, W. J., Liao, M. L., et al. (1987). Lung cancer and prior tuberculosis infection in Shanghai. British Journal of Cancer, 56, 501\u2013504.","journal-title":"British Journal of Cancer"},{"issue":"21","key":"10128_CR16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1001\/archinte.168.21.2326","volume":"168","author":"YY Yu","year":"2008","unstructured":"Yu, Y. Y., Pinsky, P. F., Caporaso, N. E., Chatterjee, N., Baumgarten, M., Langenberg, P., Furuno, J. P., Lan, Q., & Engels, E. A. (2008). Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Archives of Internal Medicine, 168(21), 2326\u20132332.","journal-title":"Archives of Internal Medicine"},{"key":"10128_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.5588\/ijtld.15.0783","volume":"20","author":"R Everatt","year":"2016","unstructured":"Everatt, R., Kuzmickiene, I., Davidaviciene, E., et al. (2016). Incidence of lung cancer among patients with tuberculosis: A nationwide cohort study in Lithuania. The International Journal of Tuberculosis and Lung Disease, 20, 757\u2013763.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10128_CR18","doi-asserted-by":"publisher","first-page":"e2352","DOI":"10.1097\/MD.0000000000002352","volume":"95","author":"VY Su","year":"2016","unstructured":"Su, V. Y., Yen, Y. F., Pan, S. W., et al. (2016). Latent tuberculosis infection and the risk of subsequent cancer. Medicine (Baltimore), 95, e2352.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10128_CR19","doi-asserted-by":"publisher","first-page":"e0250531","DOI":"10.1371\/journal.pone.0250531","volume":"16","author":"LJ Ho","year":"2021","unstructured":"Ho, L. J., Yang, H. Y., Chung, C. H., Chang, W. C., Yang, S. S., Sun, C. A., Chien, W. C., & Su, R. Y. (2021). Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study. PLoS ONE, 16(5), e0250531.","journal-title":"PLoS ONE"},{"key":"10128_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/1055-9965.EPI-10-1166","volume":"20","author":"MS Shiels","year":"2011","unstructured":"Shiels, M. S., Albanes, D., Virtamo, J., et al. (2011). Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiology, Biomarkers & Prevention, 20, 672\u2013678.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10128_CR21","first-page":"283","volume":"45","author":"AM Manning","year":"1995","unstructured":"Manning, A. M., Bell, F. P., Rosenbloom, C. L., et al. (1995). NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. Journal of Inflammation, 45, 283\u2013296.","journal-title":"Journal of Inflammation"},{"key":"10128_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"FMA Balkwill","year":"2001","unstructured":"Balkwill, F. M. A. (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539\u2013545.","journal-title":"Lancet"},{"key":"10128_CR23","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/444545","volume":"192","author":"KBH Dheda","year":"2005","unstructured":"Dheda, K. B. H., Huggett, J. F., Johnson, M. A., et al. (2005). Lung remodeling in pulmonary tuberculosis. The Journal of Infectious Diseases, 192, 1201\u20131209.","journal-title":"The Journal of Infectious Diseases"},{"key":"10128_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1534735403256332","volume":"2","author":"C Ardies","year":"2003","unstructured":"Ardies, C. (2003). Inflammation as cause for scar cancers of the lung. Integrative Cancer Therapies, 2, 238\u2013246.","journal-title":"Integrative Cancer Therapies"},{"key":"10128_CR25","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/s41467-018-04355-w","volume":"9","author":"A Porrello","year":"2018","unstructured":"Porrello, A., Leslie, P. L., Harrison, E. B., Gorentla, B. K., Kattula, S., Ghosh, S. K., et al. (2018). Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nature Communications, 9, 1988.","journal-title":"Nature Communications"},{"key":"10128_CR26","doi-asserted-by":"publisher","first-page":"e8459","DOI":"10.1371\/journal.pone.0008459","volume":"4","author":"Z Hasan","year":"2009","unstructured":"Hasan, Z., Cliff, J. M., Dockrell, H. M., et al. (2009). CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS One, 4, e8459.","journal-title":"PLoS One"},{"key":"10128_CR27","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/s41467-018-04355-w","volume":"9","author":"A Porrello","year":"2018","unstructured":"Porrello, A., Leslie, P. L., Harrison, E. B., et al. (2018). Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nature Communications, 9, 1988.","journal-title":"Nature Communications"},{"issue":"6","key":"10128_CR28","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1200\/JCO.2012.46.0667","volume":"32","author":"N Shetty","year":"2014","unstructured":"Shetty, N., Noronha, V., Joshi, A., et al. (2014). Diagnostic and treatment dilemma of dual pathology of lung cancer and disseminated tuberculosis. Journal of Clinical Oncology, 32(6), e7-9.","journal-title":"Journal of Clinical Oncology"},{"key":"10128_CR29","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.athoracsur.2011.06.055","volume":"92","author":"Y Saito","year":"2011","unstructured":"Saito, Y., Kawai, Y., Takahashi, N., Ikeya, T., Murai, K., Kawabata, Y., et al. (2011). Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. The Annals of Thoracic Surgery, 92, 1812\u20131817.","journal-title":"The Annals of Thoracic Surgery"},{"key":"10128_CR30","first-page":"w13855","volume":"143","author":"W Ren","year":"2013","unstructured":"Ren, W., Mi, D., Yang, K., Cao, N., Tian, J., Li, Z., et al. (2013). The expression of hypoxia-inducible factor-1alpha and its clinical significance in lung cancer: A systematic review and meta-analysis. Swiss Medical Weekly, 143, w13855.","journal-title":"Swiss Medical Weekly"},{"key":"10128_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K., & Carmeliet, P. (2011). Hypoxia and inflammation. The New England Journal of Medicine, 364, 656\u2013665.","journal-title":"The New England journal of medicine."},{"key":"10128_CR32","doi-asserted-by":"publisher","first-page":"10070","DOI":"10.1038\/s41598-018-28297-x","volume":"8","author":"C Li","year":"2018","unstructured":"Li, C., Rezov, V., Joensuu, E., Vartiainen, V., Ronty, M., Yin, M., et al. (2018). Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo. Scientific Reports, 8, 10070.","journal-title":"Scientific Reports"},{"key":"10128_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.resinv.2017.12.001","volume":"56","author":"Y Tanino","year":"2018","unstructured":"Tanino, Y. (2018). Does pirfenidone have anticancer effects in patients with idiopathic pulmonary fibrosis? Respiratory Investigation, 56, 95\u201396.","journal-title":"Respiratory Investigation"},{"issue":"2","key":"10128_CR34","first-page":"853","volume":"24","author":"W Zhou","year":"2019","unstructured":"Zhou, W., & Guo, Z. L. M. W. D. C. L. Z. L. (2019). Taxifolin inhibits the scar cell carcinoma growth by inducing apoptosis, cell cycle arrest and suppression of PI3K\/AKT\/mTOR pathway. Journal of B.U.ON., 24(2), 853\u2013858.","journal-title":"Journal of B.U.ON."},{"issue":"8","key":"10128_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00403-018-1849-1","volume":"310","author":"G Wei","year":"2018","unstructured":"Wei, G., Xu, Q., Liu, L., Zhang, H., Tan, X., Zhang, C., Han, C., Guo, Y., Han, G., & Zhang, C. (2018). LY2109761 reduces TGF-\u03b21-induced collagen production and contraction in hypertrophic scar fibroblasts. Archives of Dermatological Research, 310(8), 615\u2013623.","journal-title":"Archives of Dermatological Research"},{"key":"10128_CR36","doi-asserted-by":"publisher","first-page":"e36354","DOI":"10.7554\/eLife.36354","volume":"7","author":"MG Jones","year":"2018","unstructured":"Jones, M. G., Andriotis, O. G., Roberts, J. J., Lunn, K., Tear, V. J., Cao, L., et al. (2018). Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis. eLife, 7, e36354.","journal-title":"eLife"},{"issue":"6","key":"10128_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.21.01497","volume":"40","author":"M Reck","year":"2022","unstructured":"Reck, M., Remon, J., & Hellmann, M. D. (2022). First-line immunotherapy for non-small-cell lung cancer. Journal of Clinical Oncology, 40(6), 586\u2013597.","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10128_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10388-022-00970-1","volume":"20","author":"K Kato","year":"2023","unstructured":"Kato, K., Doki, Y., Ogata, T., Motoyama, S., Kawakami, H., Ueno, M., Kojima, T., Shirakawa, Y., Okada, M., Ishihara, R., Kubota, Y., Amaya-Chanaga, C., Chen, T., Matsumura, Y., & Kitagawa, Y. (2023). First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: A Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648\/ONO-4538\u201350). Esophagus, 20(2), 291\u2013301.","journal-title":"Esophagus"},{"key":"10128_CR39","doi-asserted-by":"crossref","unstructured":"Goto T.(2018). Measuring surgery outcomes of lung cancer patients with concomitant pulmonary fibrosis: A review of the literature. Cancers :10","DOI":"10.3390\/cancers10070223"},{"key":"10128_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/1097-0142(196205\/06)15:3<504::AID-CNCR2820150310>3.0.CO;2-9","volume":"15","author":"PB Hukill","year":"1962","unstructured":"Hukill, P. B., & Stern, H. (1962). Adenocarcinoma of the lung-histological factors affecting prognosis. A study of 38 patients with resection and 5-year follow-up. Cancer, 15, 504\u2013514.","journal-title":"Cancer"},{"key":"10128_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/path.1700830134","volume":"83","author":"R Carroll","year":"1962","unstructured":"Carroll, R. (1962). The influence of lung scars on primary lung cancer. The Journal of Pathology and Bacteriology, 83, 293\u20137.","journal-title":"The Journal of Pathology and Bacteriology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-023-10128-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10128-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T02:22:29Z","timestamp":1697595749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-023-10128-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10128"],"URL":"https:\/\/doi.org\/10.1007\/s10555-023-10128-9","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work comprehensively complies with the principles of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}